The Donor semen specimens are in full compliance with the Health Canada/Food and Drugs Act – Processing and Distribution of Semen for Assisted Conception Regulations, 1996, 2000; the Health Canada Directive: Technical Requirements for Therapeutic Donor Insemination, July 2000, and the Assisted Human Reproduction (AHR) Act, 2004.
A typical Testing Schedule for a Donor Candidate includes:
| 1. |
First interview and semen analysis. Non-identifying information is obtained:
- donation agreements
- medical-genetic history
- donor personality profile
- semen analysis
- exclusionary criteria screening |
| 2. |
Second interview and semen analysis. |
| 3. |
Third semen analysis. Serological / virological / genetic / microbiological testing. |
| 4. |
Psychological Assessment. |
| 5. |
Fourth semen analysis and physical examination. |
| 6. |
Assessment and evaluation for acceptance or rejection. |
At any time during this 6 months period of evaluation, the candidate may be rejected. ReproMed accepts less that 5% of those men who apply to become part of our semen donor program. You may find it comforting to know that before any semen specimens are allowed out of quarantine, ReproMed’s semen donor had had 214 serology, virology, bacteriology, and semen tests performed. Listed below are the laboratory tests currently used for donors:
TEST |
INITIAL
APPLICANT
SCREENING |
SIX
MONTHLY |
MONTHLY |
EVERY
SPECIMEN |
HIV 1/2 |
X |
x |
x |
|
HTLV 1/2 |
X |
x |
x |
|
HEP C ANTIBODY |
X |
x |
x |
|
HEP Bs ANTIBODY |
X |
x |
x |
|
HEP B CORE AB |
X |
x |
x |
|
HEP Bs ANTIGEN |
X |
x |
x |
|
C. TRACHOMATIS |
X |
x |
x |
X |
N. GONORRHOEA |
X |
x |
x |
X |
SEMEN CULTURE |
X |
X |
x |
x |
SYPHILIS (RPR) |
X |
X |
x |
|
SYPHILIS (trep. Specific) |
X |
X |
X |
|
CMV ANTIBODY (IgG, IgM) |
X |
x |
X |
|
BLOOD GROUP + Rh factor |
X |
|
|
|
SGPT (ALT) |
X |
X |
|
|
SEMEN WBC |
X |
|
|
|
SEMEN MORPHOLOGY |
X |
|
|
|
CMV CULTURE |
X |
x |
X |
|
HERPES SIMPLEX CULTURE |
X |
x |
X |
|
MYCOPLASMA/
UREAPLASMA |
X |
X |
|
|
MAR SCREENING |
X |
|
|
|
WEST NILE VIRUS (NAAT) |
X |
x |
X |
|
SARS/WNv CLINICAL SYMPTOM SCREENING |
X |
x |
x |
x |
SICKLING TEST* |
X |
|
|
|
HB ELECTROPHORESIS |
X |
|
|
|
CYSTIC FIBROSIS SCREEN* |
X |
|
|
|
KARYOTYPE |
X |
|
|
|
TAY-SACHS SCREEN* |
X |
|
|
|
*Donors are tested for Cystic Fibrosis carrier status, and have less than a 1% risk of transmission. Donors belonging to a high-risk population for Tay Sachs, Sickle Cell Anemia or Thalassemia are tested for these disorders |
Welcome
